CIK: 0001807489 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 14, 2024
Total Value ($000): $135,333 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WVE | WAVE LIFE SCIENCES LTD | 7,000,000 | $43,190 | 31.9% | $3.40 | +47.4% | SHS | Y95308105 |
| IVVD | INVIVYD INC | 9,248,250 | $41,062 | 30.3% | $17.64 | -76.6% | COM | 00534A102 |
| GUTS | FRACTYL HEALTH INC | 1,856,117 | $13,735 | 10.1% | $8.42 | 0.0% | COM | 35168W103 |
| RCKT | ROCKET PHARMACEUTICALS INC | 385,680 | $10,390 | 7.7% | $23.75 | +19.6% | COM | 77313F106 |
| SLN | SILENCE THERAPEUTICS PLC | 299,400 | $6,467 | 4.8% | $9.41 | — | ADS | 82686Q101 |
| — | SPRINGWORKS THERAPEUTICS INC | 110,400 | $5,434 | 4.0% | $25.89 | — | COM | 85205L107 |
| CRIS | CURIS INC | 421,951 | $4,587 | 3.4% | $12.87 | -16.5% | COM | 231269309 |
| BBIO | BRIDGEBIO PHARMA INC | 121,200 | $3,748 | 2.8% | $39.38 | -13.6% | COM | 10806X102 |
| TGTX | TG THERAPEUTICS INC | 161,600 | $2,458 | 1.8% | $15.49 | +2.8% | COM | 88322Q108 |
| PRQR | PROQR THRAPEUTICS N V | 1,019,498 | $2,335 | 1.7% | $2.38 | -10.2% | SHS EURO | N71542109 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 67,400 | $1,928 | 1.4% | $33.13 | -3.4% | COM | 04280A100 |